pfizer inc (PFE:New York Consolidated)
Mikael Dolsten M.D., Ph.D.
President of Worldwide Research & Development, Pfizer Inc.
|Age||Total Calculated Compensation||This person is connected to 49 board members in 2 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Prof. Mikael Dolste, MD, Ph.D., has been the President of Worldwide Research and Development at Pfizer Inc. since December 2010. Prior to joining Pfizer in 2009, Prof. Dolsten was Senior vice president of Wyeth and President of Wyeth Research where he was responsible for the global R&D division and led scientists across the US, Europe and Asia. Before joining Wyeth, he served as Executive vice president at Boehringer Ingelheim, where he was responsible for worldwide ...
235 East 42nd StreetPhone: 212-733-2323
New York, New York 10017
Board Members Memberships*
Weizmann Institute Of Science
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Paul Bulcke B.E.||Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee|
|Alan George Lafley||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
The Procter & Gamble Company
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.3M||Compensation as of Fiscal Year 2014.|